Priority Historically, the EPO have assessed formal entitlement to priority quite strictly. In scenarios where a priority application is filed by joint applicants, all of them, or their respective successors in title, must be named on the subsequent priority claiming...
The EPO fee changes effective 1 April 2024 (announced here) appear to be more than the usual inflationary increase of official fees. Rather, there appears to be a restructuring which, according to the EPO, will “include reductions for small companies and even the...
Background Dr Thaler filed two UK patent applications, one for a new food/beverage container and another for a new light beacon. As part of the application process, Form 7’s were filed at the UK Intellectual Property Office (UKIPO) stating that the inventor for...
When the EPO’s Enlarged Board of Appeal issued its decision in G 2/21 (the “plausibility” referral), many were left wondering what the requirements were for a patent applicant/proprietor to be able to rely on post-filed evidence in support of inventive step. However,...
Background – Skinny Labelling Enacted by the Hatch–Waxman Act In 1984, the US Congress introduced a law called the Drug Price Competition and Patent Term Restoration Act, or the “Hatch–Waxman” Act after the two sponsors of the bill: Representative Henry Waxman and...
Recent Comments